Oxford BioDynamics Plc
LSE: OBD.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Iain Gladstone Ross
- Employees
- 51
- Headquarters
- Oxford, United Kingdom
- IPO year
- 2016
- Market cap
- £3.8M
- Website
- https://www.oxfordbiodynamics.com
Loading OBD…
Loading profile data…Frequently asked questions about OBD
What does Oxford BioDynamics Plc (OBD.L) do?
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known...
Where does OBD.L trade?
Oxford BioDynamics Plc (OBD.L) trades on the London Stock Exchange.
What sector is OBD.L in?
Oxford BioDynamics Plc (OBD.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oxford BioDynamics Plc?
Iain Gladstone Ross is the chief executive officer of Oxford BioDynamics Plc (OBD.L).
Where is Oxford BioDynamics Plc headquartered?
Oxford BioDynamics Plc is headquartered in United Kingdom.
Does OBD.L pay a dividend?
Oxford BioDynamics Plc (OBD.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OBD.L go public?
Oxford BioDynamics Plc (OBD.L) completed its initial public offering in 2016.